Low-Dose Anti-Thymocyte Globulin (ATG) Preserves β-Cell Function and Improves HbA1c in New-Onset Type 1 DiabetesMichael J. Haller, W. J. Russell, Åke Lernmark et al.|Diabetes Care|2018Cited by 183